Home/Filings/4/0001555280-24-000339
4//SEC Filing

Polzer Robert J 4

Accession 0001555280-24-000339

CIK 0001555280other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:27 PM ET

Size

15.0 KB

Accession

0001555280-24-000339

Insider Transaction Report

Form 4
Period: 2024-11-25
Polzer Robert J
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2024-11-25$160.62/sh+1,057$169,7754,306 total
  • Exercise/Conversion

    Common Stock

    2024-11-25$162.07/sh+2,420$392,2096,726 total
  • Sale

    Common Stock

    2024-11-25$177.46/sh3,477$617,0283,249 total
  • Exercise/Conversion

    Stock Option

    2024-11-251,0575,455 total
    Common Stock (1,057 underlying)
  • Exercise/Conversion

    Stock Option

    2024-11-252,4204,840 total
    Exercise: $162.07Common Stock (2,420 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,059.858
  • Stock Option

    Exercise: $196.14Common Stock (7,107 underlying)
    7,107
Footnotes (10)
  • [F1]The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.45 to $177.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F10]One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024.
  • [F2]Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of September 30, 2024.
  • [F3]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
  • [F4]1,057 options granted February 10, 2021 at an exercise price of $160.62 per option.
  • [F5]Each option vests on the third anniversary of the date of grant.
  • [F6]Each option expires on the tenth anniversary of the date of grant.
  • [F7]5,455 options granted February 8, 2022 at an exercise price of $201.30 per option.
  • [F8]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
  • [F9]One-third of each option vests on the first, second and third anniversaries of the date of grant, February 8, 2023.

Issuer

Zoetis Inc.

CIK 0001555280

Entity typeother

Related Parties

1
  • filerCIK 0001900620

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:27 PM ET
Size
15.0 KB